WO1999007720A3 - Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes - Google Patents
Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes Download PDFInfo
- Publication number
- WO1999007720A3 WO1999007720A3 PCT/IB1998/001188 IB9801188W WO9907720A3 WO 1999007720 A3 WO1999007720 A3 WO 1999007720A3 IB 9801188 W IB9801188 W IB 9801188W WO 9907720 A3 WO9907720 A3 WO 9907720A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acarbose
- purification
- diabetes
- treatment
- pharmaceutical composition
- Prior art date
Links
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 title abstract 3
- 229960002632 acarbose Drugs 0.000 title abstract 3
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000010828 elution Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Quinoline Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Abstract
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU83542/98A AU8354298A (en) | 1997-08-05 | 1998-08-03 | A process for the purification of acarbose |
| JP2000506222A JP2001512738A (en) | 1997-08-05 | 1998-08-03 | Purification method of acabose, pharmaceutical composition containing the same, and use thereof for diabetes |
| EP98933857A EP1003761A2 (en) | 1997-08-05 | 1998-08-03 | A process for the purification of acarbose |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI97A001880 | 1997-08-05 | ||
| IT97MI001880A IT1293819B1 (en) | 1997-08-05 | 1997-08-05 | PROCEDURE FOR THE PREPARATION OF ACARBOSE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1999007720A2 WO1999007720A2 (en) | 1999-02-18 |
| WO1999007720A3 true WO1999007720A3 (en) | 1999-04-15 |
Family
ID=11377722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB1998/001188 WO1999007720A2 (en) | 1997-08-05 | 1998-08-03 | Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1003761A2 (en) |
| JP (1) | JP2001512738A (en) |
| AU (1) | AU8354298A (en) |
| IT (1) | IT1293819B1 (en) |
| WO (1) | WO1999007720A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3992497B2 (en) * | 1999-10-28 | 2007-10-17 | チョン・クン・ダン・ファーマシューティカル・コーポレーション | High purity acarbose manufacturing method |
| US20020111320A1 (en) * | 2000-08-07 | 2002-08-15 | Vilmos Keri | Method for purification of acarbose |
| HRP20010792A2 (en) * | 2001-10-26 | 2003-04-30 | Pliva D D | Acarbose purification process |
| TWI280281B (en) * | 2003-12-02 | 2007-05-01 | Cpc Corp Taiwan | A novel process to recover and purify acarbose from fermentation broth |
| CN102030786A (en) * | 2010-11-12 | 2011-04-27 | 丽珠集团新北江制药股份有限公司 | Preparation method of acarbose |
| CN102603822B (en) * | 2012-02-21 | 2013-07-03 | 河北华荣制药有限公司 | Method for improving purity of acarbose |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2347782A1 (en) * | 1973-09-22 | 1975-04-10 | Bayer Ag | AMINO SUGAR DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
| DE2719912A1 (en) * | 1977-05-04 | 1978-11-16 | Bayer Ag | METHOD OF INSULATION FROM 0 CURVED CLAMP ON -4,6-DIDEOXY-4 ANGULAR CLAMP ON ANGULAR CLAMP ON 1 S- (1,4,6 / 5) -4,5,6-TRIHYDROXY-3-HYDROXYMETHYL-2-CYCLOHEXEN -1-YL SQUARE CLIP CLOSE -AMINO SQUARE CLIP CLOSE -ALPHA-D-GLUCOPYRANOSYL CURVED CLIP CLOSE - (1- RIGHT ARROW 4) -0- ALPHA-D-GLUCOPYRANOSYL- (1- RIGHT ARROW 4) -D- GLUCOPYRANOSE FROM BRUSH |
| EP0226121A2 (en) * | 1985-12-13 | 1987-06-24 | Bayer Ag | Composition containing very pure acarbose |
| US4767850A (en) * | 1984-10-25 | 1988-08-30 | Bayer Aktiengesellschaft | Process for the purification of acarbose with polymers |
-
1997
- 1997-08-05 IT IT97MI001880A patent/IT1293819B1/en active IP Right Grant
-
1998
- 1998-08-03 EP EP98933857A patent/EP1003761A2/en not_active Withdrawn
- 1998-08-03 JP JP2000506222A patent/JP2001512738A/en active Pending
- 1998-08-03 WO PCT/IB1998/001188 patent/WO1999007720A2/en not_active Application Discontinuation
- 1998-08-03 AU AU83542/98A patent/AU8354298A/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2347782A1 (en) * | 1973-09-22 | 1975-04-10 | Bayer Ag | AMINO SUGAR DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT |
| DE2719912A1 (en) * | 1977-05-04 | 1978-11-16 | Bayer Ag | METHOD OF INSULATION FROM 0 CURVED CLAMP ON -4,6-DIDEOXY-4 ANGULAR CLAMP ON ANGULAR CLAMP ON 1 S- (1,4,6 / 5) -4,5,6-TRIHYDROXY-3-HYDROXYMETHYL-2-CYCLOHEXEN -1-YL SQUARE CLIP CLOSE -AMINO SQUARE CLIP CLOSE -ALPHA-D-GLUCOPYRANOSYL CURVED CLIP CLOSE - (1- RIGHT ARROW 4) -0- ALPHA-D-GLUCOPYRANOSYL- (1- RIGHT ARROW 4) -D- GLUCOPYRANOSE FROM BRUSH |
| US4767850A (en) * | 1984-10-25 | 1988-08-30 | Bayer Aktiengesellschaft | Process for the purification of acarbose with polymers |
| EP0226121A2 (en) * | 1985-12-13 | 1987-06-24 | Bayer Ag | Composition containing very pure acarbose |
Non-Patent Citations (1)
| Title |
|---|
| SHIBATA, YASUSHI ET AL: "Synthesis of pseudo-oligosaccharide glycosidase inhibitors. Part VII. Total synthesis of acarbose and adiposin-2", CARBOHYDR. RES. (1989), 189, 309-22, XP002091224 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1003761A2 (en) | 2000-05-31 |
| AU8354298A (en) | 1999-03-01 |
| ITMI971880A1 (en) | 1999-02-05 |
| WO1999007720A2 (en) | 1999-02-18 |
| JP2001512738A (en) | 2001-08-28 |
| IT1293819B1 (en) | 1999-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL109579A0 (en) | Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
| AU1819088A (en) | New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| ZA975866B (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases. | |
| UA29450C2 (en) | Derivatives of hydroxamic acid, a PROCESS for PREPARATION thereof, a method for influence on diseases and pharmaceutical composition containing them | |
| FI942075L (en) | Tetrazole derivatives of bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals | |
| AU8163394A (en) | Treatment of diabetes by administration of myo-inositol | |
| CA2192418A1 (en) | New crystal modification of cdch, a process for its preparation and pharmaceutical formulations comprising this modification | |
| AU2705588A (en) | New ciclosporin crystal form, processes for its production, pharmaceutical compositions containing it and its use. | |
| GR3000472T3 (en) | Azacyclic compounds, processes for their preparation, and their use as pharmaceuticals | |
| WO1999007720A3 (en) | Process for the purification of acarbose, pharmaceutical composition containing same and its use for the treatment of diabetes | |
| AU5100685A (en) | New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them | |
| GR3033416T3 (en) | Fluorophenyl substituted alkenyl carboxylic acid guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agent as well as a medicament containing them | |
| PT95212A (en) | A process for the preparation of a composition for topical use in the treatment of capillary fragility comprising defibrotide | |
| GR3032363T3 (en) | Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them | |
| SI0748795T1 (en) | Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them | |
| FR2704773B1 (en) | Process for the preparation of catalysts which can be used in dehydrogenation. | |
| AU2869489A (en) | Novel amino acid glycerides, processes for their preparation, medicaments containing them and their use | |
| CA2175201A1 (en) | Human activated protein c and process for preparing same | |
| CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
| SI0754680T1 (en) | 4-Fluoroalkyl-substituted benzoylguanidines, process for their preparation, their use as medicament as well as medicaments containing them | |
| CA2053604A1 (en) | Improved method for the purification of acetaminophen | |
| AU1630188A (en) | Substituted compounds, processes for their preparation and their use as medicaments | |
| EP0220653A3 (en) | 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, process for preparation and use thereof, and pharmaceutical composition containing the same | |
| FR2709753B1 (en) | Organic nitrates, process for their preparation and their use as medicaments. | |
| AU6797987A (en) | A column for mass transfer and/or heat exchange and for the performance of cocurrent and counter-current chemical reactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: KR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1998933857 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09720919 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1998933857 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1998933857 Country of ref document: EP |